Anzu Partners — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
TeraPore Technologiesterapore.cominSeries A · Mar 2018 · $6M
TeraPore develops nanofiltration products based on self-assembled block copolymer membrane technology for critical separation applications, including virus filtration for therapeutic proteins and biologics and semiconductor manufacturing.
BiotechDeep TechNew MaterialsSouth San Francisco, US
Rachel M. Dorin(Executive Officer, Director)in
BoardStuart Berkowitz(Director)David Seldin(Director)David Michael(Director)inMark Hurwitz(Director)
Co-investorsArtiman VenturesRA Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.